Both this novel therapeutic and Wegovy represent notable advancements in weight management , but they function through distinct mechanisms. copyright primarily affects GLP-1 receptors, enhancing insulin https://aoifeusci024377.blogoscience.com/48556683/the-new-drug-vs-semaglutide-a-head-to-head-analysis